Investigation of safety and efficacy of budesonide inhalation suspension in the long-term use in Japanese children with bronchial asthma (open long-term extension study following study SD-004-0765).
Phase of Trial: Phase III
Latest Information Update: 17 Dec 2016
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors AstraZeneca
- 01 Apr 2009 Actual end date (1 Nov 2006) added as reported by ClinicalTrials.gov.
- 11 Jan 2008 The expected completion date for this trial was 1 Feb 2007.
- 11 Jan 2008 Status changed from in progress to completed.